Diabetes Prevention-Immune Tolerance (DiAPREV-IT) tested the safety and efficacy of ASI with GAD–Alum in non-diabetic individuals with multiple islet autoantibodies. The gene discussed is GAD1; the disease is diabetes mellitus.